Federal Health Officials Issue Contamination Warning for Shellfish Across Nine States
Federal health authorities have issued a public safety warning regarding potentially contaminated shellfish products distributed across nine states. The Food and Drug Administration is advising consumers, restaurants, and retailers to avoid certain raw oysters and Manila clams that may harbor norovirus contamination.
The contaminated shellfish originated from two sources: raw oysters from Drayton Harbor Oyster Company and Manila clams from the Lummi Indian Business Council. These products were harvested during a three-week period from February 13 through March 3, 2026, and subsequently distributed to various locations.
The affected shellfish have reached distributors in Arizona, California, Florida, Georgia, Illinois, Nevada, New York, Oregon, and Washington. Health officials are emphasizing that these products should not be consumed under any circumstances due to the risk of norovirus infection.
Norovirus contamination poses significant health risks, particularly causing gastrointestinal distress including nausea, vomiting, diarrhea, and abdominal pain. Individuals with weakened immune systems face heightened vulnerability to severe complications from consuming contaminated shellfish.
Safety Recommendations for Food Establishments
The FDA is directing food service establishments and retail outlets to immediately cease serving or selling the identified shellfish products. Businesses are advised to either dispose of the contaminated items or coordinate with distributors for proper destruction procedures.
Cross-contamination prevention measures are crucial for establishments that may have handled these products. Food service workers must thoroughly wash their hands with warm soapy water after any contact with the shellfish. All storage containers, preparation surfaces, and equipment that came into contact with the products require comprehensive cleaning and sanitization.
Consumer Health Guidance
Individuals who have consumed the affected shellfish and are experiencing symptoms consistent with norovirus infection should seek medical attention promptly. Healthcare providers can offer appropriate treatment and guidance for managing symptoms.
The investigation remains ongoing, with federal officials continuing to gather information about the full scope of product distribution. The FDA has committed to providing updated safety information as new details emerge from their investigation into this contamination incident.